(Q55043340)
Statements
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation (English)
1 reference
1 reference
Lech Polonski
1 reference
Christian J F Holubarsch
1 reference
Martin Rohrbach
1 reference
Matthias Karrasch
1 reference
Erich Boehm
1 reference
Siegfried Rhein
1 reference
1 August 2007
1 reference
113
1 reference
4
1 reference
205-212
1 reference